These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17519421)

  • 1. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    Pearson ER; Donnelly LA; Kimber C; Whitley A; Doney AS; McCarthy MI; Hattersley AT; Morris AD; Palmer CN
    Diabetes; 2007 Aug; 56(8):2178-82. PubMed ID: 17519421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
    Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
    Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk.
    Fisher E; Boeing H; Fritsche A; Doering F; Joost HG; Schulze MB
    Br J Nutr; 2009 Feb; 101(4):478-81. PubMed ID: 19149908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.
    Kang ES; Kim MS; Kim YS; Hur KY; Han SJ; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
    Diabetes Care; 2008 Jan; 31(1):63-8. PubMed ID: 17934151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.
    Zhou K; Donnelly L; Burch L; Tavendale R; Doney AS; Leese G; Hattersley AT; McCarthy MI; Morris AD; Lang CC; Palmer CN; Pearson ER
    Clin Pharmacol Ther; 2010 Jan; 87(1):52-6. PubMed ID: 19794412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
    Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
    Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
    Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
    Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
    Thorsby PM; Midthjell K; Gjerlaugsen N; Holmen J; Hanssen KF; Birkeland KI; Berg JP
    Scand J Clin Lab Invest; 2009; 69(2):282-7. PubMed ID: 18972257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics.
    Dhawan D; Padh H
    Diabetes Res Clin Pract; 2016 Nov; 121():35-40. PubMed ID: 27639123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.
    Parra EJ; Cameron E; Simmonds L; Valladares A; McKeigue P; Shriver M; Wacher N; Kumate J; Kittles R; Cruz M
    Clin Genet; 2007 Apr; 71(4):359-66. PubMed ID: 17470138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.
    Javorsky M; Klimcakova L; Schroner Z; Zidzik J; Babjakova E; Fabianova M; Kozarova M; Tkacova R; Salagovic J; Tkac I
    Eur J Intern Med; 2012 Apr; 23(3):245-9. PubMed ID: 22385882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Cauchi S; Meyre D; Choquet H; Dina C; Born C; Marre M; Balkau B; Froguel P;
    Diabetes; 2006 Nov; 55(11):3189-92. PubMed ID: 17065361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.
    Lehman DM; Hunt KJ; Leach RJ; Hamlington J; Arya R; Abboud HE; Duggirala R; Blangero J; Göring HH; Stern MP
    Diabetes; 2007 Feb; 56(2):389-93. PubMed ID: 17259383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
    Kimber CH; Doney AS; Pearson ER; McCarthy MI; Hattersley AT; Leese GP; Morris AD; Palmer CN
    Diabetologia; 2007 Jun; 50(6):1186-91. PubMed ID: 17429603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
    Saxena R; Gianniny L; Burtt NP; Lyssenko V; Giuducci C; Sjögren M; Florez JC; Almgren P; Isomaa B; Orho-Melander M; Lindblad U; Daly MJ; Tuomi T; Hirschhorn JN; Ardlie KG; Groop LC; Altshuler D
    Diabetes; 2006 Oct; 55(10):2890-5. PubMed ID: 17003358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new type 2 diabetes gene TCF7L2.
    Florez JC
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):391-6. PubMed ID: 17563454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
    Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome.
    Christopoulos P; Mastorakos G; Gazouli M; Panidis D; Deligeoroglou E; Katsikis I; Papadias K; Diamandi-Kandarakis E; Creatsas G
    Gynecol Endocrinol; 2008 Sep; 24(9):486-90. PubMed ID: 18958766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.